Literature DB >> 16901506

Frontal lobe volumes in schizophrenia: effects of stage and duration of illness.

Preethi Premkumar1, Veena Kumari, Philip J J Corr, Tonmoy Sharma.   

Abstract

While the changes in the volume of the temporal lobe and its sub-regions over the course of illness have been studied in patients with schizophrenia, few studies have examined changes in the frontal lobe between the first episode and the chronic stage. In this study, we focussed on the effect of illness stage and duration of illness on the volume of frontal lobe regions, though we also examined several other regions to establish the specificity of any effects, if observed, in this region. We compared the volumes of brain regions among 34 first-episode schizophrenia patients, 49 chronic schizophrenia patients, 18 healthy controls matched, on average, to the first-episode patients and 21 healthy controls matched, on average, to the chronic patients. Logarithmic regression analyses examined the relationships between the duration of illness and the brain regional volumes in the patient group. The results showed that chronic patients had smaller prefrontal cortical grey matter volumes, but larger premotor cortical and putamen volumes compared to first-episode patients and matched healthy controls. Although there were significant patient-by-control group interactions in the cerebellum and sensori-motor cortical grey matter volumes, these did not survive correction for multiple comparisons. There was a significant exponential relation between the duration of illness and the volumes of prefrontal cortex, parieto-occipital cortex grey matter, thalamus and putamen, suggesting that these regions are susceptible to change as the disorder persists. The enlargement of the premotor cortex and putamen are likely to be a result of antipsychotic medication.

Entities:  

Mesh:

Year:  2006        PMID: 16901506     DOI: 10.1016/j.jpsychires.2006.05.009

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  5 in total

1.  Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness.

Authors:  Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni
Journal:  Schizophr Bull       Date:  2008-11-17       Impact factor: 9.306

2.  Three-way (N-way) fusion of brain imaging data based on mCCA+jICA and its application to discriminating schizophrenia.

Authors:  Jing Sui; Hao He; Godfrey D Pearlson; Tülay Adali; Kent A Kiehl; Qingbao Yu; Vince P Clark; Eduardo Castro; Tonya White; Bryon A Mueller; Beng C Ho; Nancy C Andreasen; Vince D Calhoun
Journal:  Neuroimage       Date:  2012-10-26       Impact factor: 6.556

Review 3.  The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences.

Authors:  Hernàn Picard; Isabelle Amado; Sabine Mouchet-Mages; Jean-Pierre Olié; Marie-Odile Krebs
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

4.  Emotional decision-making and its dissociable components in schizophrenia and schizoaffective disorder: a behavioural and MRI investigation.

Authors:  Preethi Premkumar; Dominic Fannon; Elizabeth Kuipers; Andrew Simmons; Sophia Frangou; Veena Kumari
Journal:  Neuropsychologia       Date:  2008-02-07       Impact factor: 3.139

5.  Misattribution bias of threat-related facial expressions is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder.

Authors:  Preethi Premkumar; Michael A Cooke; Dominic Fannon; Emmanuelle Peters; Tanja M Michel; Ingrid Aasen; Robin M Murray; Elizabeth Kuipers; Veena Kumari
Journal:  Eur Psychiatry       Date:  2008-01-16       Impact factor: 5.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.